Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.

The CardioMEMS HF System provided useful information to monitor PAH therapy, and demonstrated short- and long-term safety. Larger clinical trials are needed before its widespread use to guide therapy in severe PAH patients with right-sided HF.